GHK-Cu (glycyl-L-histidyl-L-lysine copper, also called copper tripeptide-1) is a naturally occurring tripeptide-copper complex first isolated from human plasma in 1973 by Dr
Safety, Sourcing, and Why Medical Oversight Is Non-Negotiable BPC-157 has a strong safety record in animal studies notably, the lethal dose (LD1) has not been achieved across decades of preclinical research, and it has been used in human ulcerative colitis and multiple sclerosis trials without reported toxicity.6 But the absence of adverse events in animals does not translate directly to human safety, particularly at unregulated doses from unverified sources
They studied 30 workers exposed to lead and a group of 27 unexposed controls
Typical Treatment Protocol at Specialized Clinics Comprehensive initial consultation and health assessment Laboratory testing to identify underlying factors Development of a personalized treatment plan Preparation and administration of the injection Post-treatment monitoring and support Follow-up assessments to track progress and adjust treatment as needed Clinics like The Lamkin Clinic typically begin with initial lab assessment and discussion of treatment options and protocol
We partner with 35 labs across the U.S
Yes, BPC-157 has been shown to support the regeneration of cartilage by stimulating growth factors, enhancing blood supply, and promoting the activity of fibroblasts and other cells involved in connective tissue repair